Tin tức & Cập nhật
Xem bài viết Tim mạch
Xem
Chỉ hiển thị Multimedia

Nebivolol mends hypertension-induced endothelial cell dysfunction
21 Sep 2026
bởiStephen Padilla
Treatment with nebivolol results in the improvement of hypertension-induced endothelial cell (EC) dysfunction by reducing the factors that contribute to cellular senescence of the endothelium, a study has shown.
21 Sep 2026

Aficamten retains upper hand over metoprolol for oHCM in subanalysis
14 Sep 2026
bởiAudrey Abella
Results from a subanalysis of the MAPLE-HCM* trial presented at ESC 2026 continue to support the superiority of aficamten over metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) irrespective of beta-blocker (BB) use at screening and prior standard-of-care (SoC) status.
14 Sep 2026






